“…Thus, cytosolic forms (hCA I–III, VII), membrane-bound (hCA IV, IX, XII, and XIV), mitochondrial form (hCA V), and secreted (hCA VI) isozymes can be distinguished . The role of hCAs in the regulation of hypoxic-tumors pH has been extensively reported, ,− and isoforms II, IX, and XII are validated targets for cancer therapy. − On the other hand, the relevant role of hCOX 1 and 2 in different tumors has been outlined. − Celecoxib, a selective hCOX-2 inhibitor, has been approved by the FDA for adjuvant treatment of patients with familial adenomatous polyposis . Furthermore, the role of Aspirin as an adjuvant agent in the prevention and treatment of several solid tumors has been reported. − Furthermore, a COX-dependent evasion of immunity has been observed in tumors .…”